Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

This publication has 16 references indexed in Scilit:

• Participation in Transvaginal Ovarian Cancer Screening: Compliance, Correlation Factors, and Costs
  Gynecologic Oncology, 1995
• Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
  BMJ, 1993
• Hereditary Ovarian Carcinoma
  Hematology/Oncology Clinics of North America, 1992
• Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five‐year cancer registry review
  BJOG: An International Journal of Obstetrics and Gynaecology, 1992
• Ultrasound screening for familial ovarian cancer
  Gynecologic Oncology, 1991
• A New CA125-like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG-II)
  Japanese Journal of Cancer Research, 1991
• Tribute to Patrick Steptoe: beginnings of laparoscopy
  Human Reproduction, 1989
• Symptomatology of ovarian cancer
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1988
• A radioimmunoassay for the detection of a human tumor‐associated glycoprotein (tag‐72) using monoclonal antibody B72.3
  International Journal of Cancer, 1986
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983